126 related articles for article (PubMed ID: 5125072)
21. Amantadine hydrochloride in the treatment of Parkinsonism. A controlled trial.
Appleton DB; Eadie MJ; Sutherland JM
Med J Aust; 1970 Oct; 2(14):626-9. PubMed ID: 4920572
[No Abstract] [Full Text] [Related]
22. [Disputable problems with regard to the main forms of parkinsonism].
Levin GZ
Klin Med (Mosk); 1977 Sep; 55(9):84-9. PubMed ID: 926744
[No Abstract] [Full Text] [Related]
23. [Amandatine hydrochloride (Symmetrel) in the treatment of parkinsonism].
Nikolić M; Lević Z
Srp Arh Celok Lek; 1976 Feb; 104(2):113-8. PubMed ID: 1013802
[No Abstract] [Full Text] [Related]
24. [Therapeutic experiences with amantadine sulfate as a monotherapeutic drug in patients with Parkinsonism].
Völler GW; Deze J
Z Allgemeinmed; 1973 May; 49(14):664-70. PubMed ID: 4585272
[No Abstract] [Full Text] [Related]
25. [Psychological status of patients with Parkinsonism during treatment with amantadine hydrochloride and L-Dopa].
Ferraris M
Minerva Med; 1971 Oct; 62(82):3971-3. PubMed ID: 5125056
[No Abstract] [Full Text] [Related]
26. [6 months of treatment with amantadine and L-Dopa. Comparison in 2 groups of patients with parkinsonism].
Buscaino GA; Campanella G; Zallone E
Minerva Med; 1971 Oct; 62(82):3974-8. PubMed ID: 5125057
[No Abstract] [Full Text] [Related]
27. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride.
Reveno WS; Bauer RB; Rosenbaum H
Geriatrics; 1971 Aug; 26(8):61-70. PubMed ID: 5096462
[No Abstract] [Full Text] [Related]
28. [Changes in cerebral visual evoked potentials in parkinsonism].
Zenkov LR; Fishman MN; Voevodskaia IV; Padalko VV
Vopr Neirokhir; 1973; 37(6):43-8. PubMed ID: 4780890
[No Abstract] [Full Text] [Related]
29. [Correlation of biochemical findings and the state of the neuromuscular apparatus in patients with parkinsonism during use of decimeter wave therapy].
Strelkova NI; Zeĭnalov RK
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):216-20. PubMed ID: 4743271
[No Abstract] [Full Text] [Related]
30. [Treatment of parkinsonism with viregyt (amantadine)].
Pryszmont M; Jankowicz E; Eljasz L; Slizewski M; Wiśniewska Z
Wiad Lek; 1974 Aug; 27(15):1371-5. PubMed ID: 4418066
[No Abstract] [Full Text] [Related]
31. Experiences with amantadine hydrochloride in Parkinson's disease.
Griffiths AV; Parker WN; Palmer RM
Practitioner; 1971 Nov; 207(241):679-80. PubMed ID: 5134819
[No Abstract] [Full Text] [Related]
32. [Effectiveness of a combination therapy in the Parkinson syndrome by amantadine hydrochloride and anticholinergic agents].
Gospavić J; Vidaković Z
Srp Arh Celok Lek; 1974 Jun; 102(6):447-57. PubMed ID: 4450143
[No Abstract] [Full Text] [Related]
33. Amantadine hydrochloride in the treatment of Parkinson's disease.
Nagaswami S; Ranjini R
J Kans Med Soc; 1971 Nov; 72(11):465-8. PubMed ID: 5120698
[No Abstract] [Full Text] [Related]
34. [Treatment with midantan of patients with parkinsonism].
Kadykov AS
Sov Med; 1973 Sep; 36(9):143. PubMed ID: 4756486
[No Abstract] [Full Text] [Related]
35. Amantadine in Parkinsonism. An extended prospective trial.
Rao NS; Pearce J
Practitioner; 1971 Feb; 206(232):241-5. PubMed ID: 4928964
[No Abstract] [Full Text] [Related]
36. [Action of amantadine HCl alone and in combination with L-dopa on parkinsonism].
Danielczyk W; Korten JJ
Med Monatsschr; 1971 Oct; 25(10):472-9. PubMed ID: 5122447
[No Abstract] [Full Text] [Related]
37. Amphetamines in the treatment of Parkinson's disease.
Parkes JD; Tarsy D; Marsden CD; Bovill KT; Phipps JA; Rose P; Asselman P
J Neurol Neurosurg Psychiatry; 1975 Mar; 38(3):232-7. PubMed ID: 1097600
[TBL] [Abstract][Full Text] [Related]
38. [The treatment of Parkinson's disease with levodopa. Principles. Practical advice. Considerations].
Sigwald J
Nouv Presse Med; 1972 Mar; 1(10):679-82. PubMed ID: 5022921
[No Abstract] [Full Text] [Related]
39. Double blind study using amantadine hydrochloride in the therapy of Parkinson's disease.
Silver DE; Sahs AL
Trans Am Neurol Assoc; 1971; 96():307-8. PubMed ID: 4945919
[No Abstract] [Full Text] [Related]
40. [Long-time therapy of Parkinsonism with amantadine sulfate. Reply to L.W. Diehl: "Nil nocere. Adverse effects of amantadine therapy of parkinsonism"].
Fünfgeld EW
Munch Med Wochenschr; 1972 Jun; 114(22):1064-5. PubMed ID: 5068021
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
